Soligenix, Inc. (SNGX) SEC Filings — 2024

Filings

• Soligenix Reports Q3 2024 Results: Net Loss Narrows — 10-Q · Nov 8, 2024
• Soligenix, Inc. Enters Material Definitive Agreement — 8-K · Oct 11, 2024
• Soligenix, Inc. Files 8-K Report — 8-K · Aug 16, 2024
• Soligenix, Inc. Files 10-Q for Q2 2024 — 10-Q · Aug 9, 2024
• Soligenix, Inc. Signs Material Definitive Agreement — 8-K · Jul 25, 2024
• Soligenix Files S-1 with SEC — S-1 · Jul 24, 2024
• Soligenix, Inc. Files 8-K with Material Agreement Details — 8-K · Jul 9, 2024
• Soligenix 8-K: Corporate Governance & Security Holder Updates — 8-K · May 31, 2024
• Soligenix Files Proxy Statement for Annual Meeting — DEFA14A · May 29, 2024
• Soligenix Files Proxy Statement — DEFA14A · May 28, 2024
• Soligenix, Inc. Files 8-K: Shareholder Vote, Reg FD, Financials — 8-K · May 24, 2024
• Soligenix Files Proxy Materials — DEFA14A · May 22, 2024
• Soligenix, Inc. Files 8-K: Other Events & Financials — 8-K · May 17, 2024
• Soligenix Files Proxy Materials — DEFA14A · May 15, 2024
• SOLIGENIX, INC. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 10, 2024
• Soligenix Advances Rare Disease Pipeline, Focuses on HyBryte™ for CTCL — DEF 14A · Apr 29, 2024
• Soligenix, Inc. Files 8-K: Material Agreement & Financials — 8-K · Apr 22, 2024
• Soligenix, Inc. Files 8-K Report — 8-K · Apr 3, 2024
• SOLIGENIX, INC. Files S-1/A Amendment — S-1/A · Apr 2, 2024
• Soligenix, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 15, 2024
• Soligenix, Inc. Files S-1 Registration Statement — S-1 · Jan 16, 2024